These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 31310826)

  • 21. Effective treatment of actinic keratosis on the hands with red light photodynamic therapy using BF-200 ALA.
    Ulrich M; Reinhold U; Dominicus R; Aschoff R; Szeimies RM; Schäning R; Zeuner MT; Pospiech N; Dirschka T
    Photodiagnosis Photodyn Ther; 2024 Oct; 49():104280. PubMed ID: 39002836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current methods for photodynamic therapy in the US: comparison of MAL/PDT and ALA/PDT.
    Lee PK; Kloser A
    J Drugs Dermatol; 2013 Aug; 12(8):925-30. PubMed ID: 23986167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term Outcome of Daylight Photodynamic Therapy with Amino-5-laevulinate Nanoemulsion vs. Methyl-5-aminolaevulinate for Actinic Keratoses.
    Neittaanmäki-Perttu N; Grönroos M; Tani T; Snellman E
    Acta Derm Venereol; 2016 Jun; 96(5):712-3. PubMed ID: 26806126
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment with 5-aminolaevulinic acid methylester is less painful than treatment with 5-aminolaevulinic acid nanoemulsion in topical photodynamic therapy for actinic keratosis.
    Gholam P; Weberschock T; Denk K; Enk A
    Dermatology; 2011; 222(4):358-62. PubMed ID: 21757880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spanish-Portuguese consensus statement on use of daylight-mediated photodynamic therapy with methyl aminolevulinate in the treatment of actinic keratosis.
    Gilaberte Y; Aguilar M; Almagro M; Correia O; Guillén C; Harto A; Pérez-García B; Pérez-Pérez L; Redondo P; Sánchez-Carpintero I; Serra-Guillén C; Valladares LM
    Actas Dermosifiliogr; 2015 Oct; 106(8):623-31. PubMed ID: 26115793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness and safety of 0·5% colchicine cream vs. photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis and skin field cancerization of the forearms: a randomized controlled trial.
    Miola AC; Ferreira ER; Lima TRR; Schmitt JV; Abbade LPF; Miot HA
    Br J Dermatol; 2018 Nov; 179(5):1081-1087. PubMed ID: 29862491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short incubation with methyl aminolevulinate for photodynamic therapy of actinic keratoses.
    Braathen LR; Paredes BE; Saksela O; Fritsch C; Gardlo K; Morken T; Frølich KW; Warloe T; Solér AM; Ros AM
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):550-5. PubMed ID: 19415804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy.
    Morton CA; Dominicus R; Radny P; Dirschka T; Hauschild A; Reinhold U; Aschoff R; Ulrich M; Keohane S; Ekanayake-Bohlig S; Ibbotson S; Ostendorf R; Berking C; Gröne D; Schulze HJ; Ockenfels HM; Jasnoch V; Kurzen H; Sebastian M; Stege H; Staubach P; Gupta G; Hübinger F; Ziabreva I; Schmitz B; Gertzmann A; Lübbert H; Szeimies RM
    Br J Dermatol; 2018 Aug; 179(2):309-319. PubMed ID: 29432644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Pharmacokinetics and Safety of a 10% Aminolevulinic Acid Hydrochloride Nanoemulsion Gel (BF-200 ALA) in Photodynamic Therapy of Patients Extensively Affected With Actinic Keratosis: Results of 2 Maximal Usage Pharmacokinetic Trials.
    Novak B; DuBois J; Chahrour O; Papusha T; Hirt S; Philippi T; Zogel C; Osenberg K; Schmitz B; Lübbert H
    Clin Pharmacol Drug Dev; 2022 Apr; 11(4):535-550. PubMed ID: 34633154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bucher's indirect comparison of daylight photodynamic therapy with methyl aminolevulinate cream versus diclofenac plus hyaluronic acid gel for the treatment of multiple actinic keratosis.
    Calzavara-Pinton P; Zane C; Pacou M; Szeimies RM
    Eur J Dermatol; 2016 Oct; 26(5):487-492. PubMed ID: 27352420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Red light photodynamic therapy with BF-200 ALA showed superior efficacy in the treatment of actinic keratosis on the extremities, trunk, and neck in a vehicle-controlled phase III study.
    Ulrich M; Reinhold U; Dominicus R; Aschoff R; Szeimies RM; Dirschka T
    J Am Acad Dermatol; 2021 Dec; 85(6):1510-1519. PubMed ID: 33744350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of photodynamic therapy vs other interventions in randomized clinical trials for the treatment of actinic keratoses: a systematic review and meta-analysis.
    Patel G; Armstrong AW; Eisen DB
    JAMA Dermatol; 2014 Dec; 150(12):1281-8. PubMed ID: 25162181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.
    Rubel DM; Spelman L; Murrell DF; See JA; Hewitt D; Foley P; Bosc C; Kerob D; Kerrouche N; Wulf HC; Shumack S
    Br J Dermatol; 2014 Nov; 171(5):1164-71. PubMed ID: 24861492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simulated-daylight photodynamic therapy with BF-200 aminolaevulinic acid for actinic keratosis: assessment of the efficacy and tolerability in a retrospective study.
    Kellner C; Bauriedl S; Hollstein S; Reinhold U
    Br J Dermatol; 2015 Apr; 172(4):1146-8. PubMed ID: 25244353
    [No Abstract]   [Full Text] [Related]  

  • 35. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study.
    Szeimies RM; Radny P; Sebastian M; Borrosch F; Dirschka T; Krähn-Senftleben G; Reich K; Pabst G; Voss D; Foguet M; Gahlmann R; Lübbert H; Reinhold U
    Br J Dermatol; 2010 Aug; 163(2):386-94. PubMed ID: 20518784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photodynamic therapy in the management of actinic keratosis: Retrospective evaluation of outcome.
    Jerjes W; Hamdoon Z; Abdulkareem AA; Hopper C
    Photodiagnosis Photodyn Ther; 2017 Mar; 17():200-204. PubMed ID: 27174210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid.
    Kasche A; Luderschmidt S; Ring J; Hein R
    J Drugs Dermatol; 2006 Apr; 5(4):353-6. PubMed ID: 16673803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Network meta-analysis of the outcome 'participant complete clearance' in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review.
    Gupta AK; Paquet M
    Br J Dermatol; 2013 Aug; 169(2):250-9. PubMed ID: 23550994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 12-month follow-up split-scalp study comparing calcipotriol-assisted MAL-PDT with conventional MAL-PDT for the treatment of actinic keratosis: a randomized controlled trial.
    Torezan L; Grinblat B; Haedersdal M; Festa-Neto C; Szeimies RM
    Eur J Dermatol; 2021 Oct; 31(5):638-644. PubMed ID: 34789450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plum-blossom needle tapping enhances the efficacy of ALA photodynamic therapy for facial actinic keratosis in Chinese population: a randomized, multicenter, prospective, and observer-blind study.
    Wang P; Xie F; Zhang L; Zhao S; Zhu L; Shen S; Li D; Chen Z; Xiao R; Lu Y; Lei X; Li Y; Zhang G; Zeng W; Wang X
    Photodiagnosis Photodyn Ther; 2023 Jun; 42():103611. PubMed ID: 37211296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.